To examine the anti-tumor potential of intratumoral immunotherapy in locally advanced disease, mice bearing large TC1 flank tumors (~700 mm3) were randomized to intratumoral inoculations of Ad.LacZ, Ad.IFNα or AdV-tk. The gene discussed is TKT; the disease is neoplasm.